SOX9 drives KRAS-induced lung adenocarcinoma progression and suppresses anti-tumor immunityHua Zhong, Sharon R. Pine, Wen Lu et al.|Oncogene|2023Cited by 26
Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell CarcinomaEileen Shiuan, Kathryn E. Beckermann, Kirsten Young et al.|Cancers|2021Cited by 16
Abstract P1-05-20: Validation of the HER2 Activation Response Predictive Signature (HARPS) as a Predictive Biomarker for HER2+ Therapy Response in the Neoadjuvant SettingEmanuel Petricoin, Shridar Ganesan, Julia Wulfkuhle et al.|Clinical Cancer Research|2025Cited by 0